Create Account | Sign In: Author or Forum

Search Symptoms

CONFERENCE NEWS

ADA: Canagliflozin Tied to Lower Risk of Cardiovascular Events

June 13, 2017. 12:00 PM EST. Lower risk versus placebo for patients with type 2 diabetes and high cardiovascular risk Read article

OTHER CONFERENCE NEWS

ASN: Multidisciplinary Care Cost-Effective in CKD

November 21, 2016 Multidisciplinary care costs $24,613 per quality-adjusted life-year gained compared to usual care

ASN: Severe Acute Kidney Injury Ups Risk of 28-Day Mortality

November 21, 2016 Increased use of mechanical ventilation, renal-replacement therapy in children with severe AKI

ASN: Smoking May Negate Some Benefits of Rx Therapy in CKD

November 18, 2016 Possibly because cigarette smoking causes oxidative stress

ASN: Acid Suppression Therapy Linked to Kidney Stones, CKD

November 18, 2016 Two studies show increased risk of kidney stones with PPI, H2 blocker use; CKD with PPI use

ASN: Tele-Nephrology Delivers Dialysis at Rural Hospital

November 17, 2016 Since program implementation in January 2016, 12 patients treated with 20 dialysis treatments

Renal-Cell Cancer Disease-Free Survival Up With Sunitinib

October 11, 2016 Findings in patients with locoregional, high-risk clear-cell renal-cell carcinoma

Health Care Workers’ Gloves Strong Source of Contamination

June 27, 2016 Clear evidence that gloves of health care workers contaminate hospital surfaces with bacteria

ADA: Empagliflozin Linked to Reduction in T2DM Nephropathy

June 14, 2016 Reduction in incident or worsening nephropathy, and in doubling of serum creatinine level

ADA: Diabetes Collaborative Registry IDs Burden of Cardiac Risk

June 14, 2016 Registry offers information on quality of diabetes care across primary, specialty care spectrum

ASCO: Immunotherapy Beneficial in Advanced Bladder Cancer

June 06, 2016 About a quarter of older patients deemed too frail for chemo responded to atezolizumab

Early Renal Replacement Therapy Ups Survival in Severe AKI

May 24, 2016 Early versus delayed initiation linked to reduced mortality over 90 days in acute kidney injury

ASCO: Phase I Cancer Drug Trials Benefit From Precision Medicine

May 20, 2016 Better outcomes for patients whose treatment is selected based on molecular characteristics of tumor

ASH: Studies Support Aggressive Treatment of HTN in Elderly

May 16, 2016 Latest findings from national trial show it lowers chances of heart failure, even in older adults

ATS: No Benefit for Early Renal-Replacement Therapy

May 16, 2016 Mortality no different for early versus delayed strategy for patients with severe acute kidney injury

Core-Needle Biopsy Effective in Evaluation of Renal Masses

March 10, 2016 Image-guided testing of tissue from the renal mass may lead to improved treatments, researchers say